Outlook Therapeutics OTLK
NASDAQ OTLK
$0.58 +0.01 (+1.48%)
As of: Oct 1, 2026 · 3:59 PM EDT

Outlook Therapeutics (OTLK) Other Non-Current Liabilities (2015 - 2026)

Updated

Outlook Therapeutics (OTLK) posted Other Non-Current Liabilities of $7.76 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 4.1% from $7.45 million a year earlier and up 974.2% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Other Non-Current Liabilities came in at $4.77 million, down 91.9% from FY2024.

  • Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of 132.1% (FY2020 to FY2025).
  • In prior fiscal years, Outlook Therapeutics' Other Non-Current Liabilities was $59.1 million in FY2024, $6,219 in FY2023 (-89.1%), $57,138 in FY2022 (-89.1%) and $522,918 in FY2021 (+638.9%).
  • The fiscal Q3 2026 figure stands as the highest quarterly Other Non-Current Liabilities since fiscal Q1 2025.
  • On a year-over-year basis, Other Non-Current Liabilities increased in 1 of the last six quarters, with an average decline of 70.3%.
  • The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was fiscal Q4 2021, with growth of 638.9%; the weakest was fiscal Q2 2023, with a decline of 97.2%.
  • According to Business Quant data, Other Non-Current Liabilities for the three prior fiscal quarters was $722,229 (Q2 2026), $7.56 million (Q1 2026) and $4.77 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Outlook Therapeutics 77.94 Mn 42.19 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.76 Mn
Mar 31, 2026 722,229.00
Dec 31, 2025 7.56 Mn
Sep 30, 2025 4.77 Mn
Jun 30, 2025 7.45 Mn
Mar 31, 2025 5.45 Mn
Dec 31, 2024 18.83 Mn
Sep 30, 2024 59.10 Mn
Jun 30, 2024 87.95 Mn
Mar 31, 2024 139.18 Mn
Dec 31, 2023 59,561.00
Sep 30, 2023 6,219.00
Jun 30, 2023 20,012.00
Mar 31, 2023 8,263.00
Dec 31, 2022 26,878.00
Sep 30, 2022 57,138.00
Jun 30, 2022 68,319.00
Mar 31, 2022 298,033.00
Dec 31, 2021 273,020.00
Sep 30, 2021 522,918.00
API Access

Outlook Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=OTLK&period=max&api_key=YOUR_API_KEY